Cord blood offered to fight lingering COVID symptoms
NCT ID NCT07332338
Summary
This program provides expanded access to an experimental treatment for people suffering from Long COVID. It will give up to 30 adults an infusion of cells from donated umbilical cord blood, called REGENECYTE, to see if it can help control their ongoing symptoms like severe fatigue. The goal is to reduce the disease burden for patients who are not eligible for other clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
D&H National Research Center #1
AVAILABLEMiami, Florida, 33169, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Myrak Research Center Inc.
AVAILABLEMiami Lakes, Florida, 33014, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.